Ownership
Private
Employees
~20000
Therapeutic Areas
Stage
Commercial
Preclinical
Phase 1
Phase 2
Phase 3
Approved
SYNLAB General Information
SYNLAB operates one of the largest clinical laboratory networks in Europe and globally. It conducts approximately 600 million tests annually across more than 30 countries. The company leads in innovation for medical diagnostics with a focus on personalized medicine and evidence-based healthcare. Its research institute IRCCS SDN SYNLAB in Naples exemplifies its commitment to translating science into clinical practice. The group collaborates extensively with universities and research centers to advance diagnostic science
Contact Information
Drug Pipeline
No pipeline data available
Key Partnerships
National Health Service (NHS) UK contract for pathology services, Collaborations with global public health institutions
SYNLAB Funding
No funding data available
To view SYNLAB's complete valuation and funding history, request access »